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Abstract
Background: Hearing impairment is the most common sensory impairment in humans, affecting 1:1,000 births. We have
identified an ENU generated mouse mutant, Mozart, with recessively inherited, non-syndromic progressive hearing loss
caused by a mutation in the synaptojanin 2 (Synj2), a central regulatory enzyme in the phosphoinositide-signaling cascade.
Methodology/Principal Findings: The hearing loss in Mozart is caused by a p.Asn538Lys mutation in the catalytic domain of
the inositol polyphosphate 5-phosphatase synaptojanin 2. Within the cochlea, Synj2 mRNA expression was detected in the
inner and outer hair cells but not in the spiral ganglion. Synj2
N538K mutant protein showed loss of lipid phosphatase activity,
and was unable to degrade phosphoinositide signaling molecules. Mutant Mozart mice (Synj2
N538K/N538K) exhibited
progressive hearing loss and showed signs of hair cell degeneration as early as two weeks of age, with fusion of stereocilia
followed by complete loss of hair bundles and ultimately loss of hair cells. No changes in vestibular or neurological function,
or other clinical or behavioral manifestations were apparent.
Conclusions/Significance: Phosphoinositides are membrane associated signaling molecules that regulate many cellular
processes including cell death, proliferation, actin polymerization and ion channel activity. These results reveal Synj2 as a
critical regulator of hair cell survival that is essential for hair cell maintenance and hearing function.
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Introduction
Deafness is an etiologically heterogeneous trait where the age of
onset, severity and site of lesion can vary. It can be caused by genetic
and/or environmental factors. Environmental risk factors include
premature birth, bacterial and viral infections, exposure to loud noise
and to ototoxic drugs (which include commonly used aminoglycoside
antibiotics such as kanamycin, neomycin and gentamycin, as well as
the anticancer drugs cisplatin and methotrexate). However, more
than 60% of congenital non-syndromic deafness is caused by
mutations in one of an estimated 200 or more ‘‘deafness’’ genes
[1]. Inherited hearing losses are usually transmitted as monogenic
disorders and most often in an autosomal recessive mode [2], the
latter accounts for approximately 80% of non-syndromic inherited
hearing loss. The identification of genes that cause deafness when
mutated has significantly improved our knowledge about the auditory
pathway and led to better genetic counseling and management of
people affected by hearing loss. Despite this, there are still large gaps
in our knowledge of genes involved in hearing loss and the molecular
mechanisms of auditory function.
Phosphoinositides are membrane-bound signaling molecules
that control many important cellular processes, such as membrane
trafficking, nucleation of actin filaments, dynamin function, and
the activity of ion channels and transporters [3,4,5]. It has been
suggested that phosphoinositides play an important role in
regulating cellular processes essential for normal hearing
[6,7,8,9], but little is known of how changes in phosphoinositide
metabolism may lead to deafness. The levels of phosphoinositide
signaling molecules, including phosphatidylinositol 4,5 bispho-
sphate (PtdIns(4,5)P2) and phosphatidylinositol 3,4,5 trisphosphate
(PtdIns(3,4,5)P3), are controlled by lipid kinases, which synthesize
these signaling molecules, and by phosphoinositide phosphatases,
which remove phosphate groups from the inositol ring and
terminate the signalling function. Synaptojanin 2 (Synj2) belongs
to a family of ten inositol polyphosphate 5-phosphatases (5-
phosphatases) that remove the 5-position phosphate from
phosphoinositides such as PtdIns(3,4,5)P3 and PtdIns(4,5)P2
forming PtdIns(3,4)P2 and PtdIns(4)P, respectively [10,11,12].
Synj2 and it’s closest family member, Synj1, contain two distinct
catalytic domains, a central 5-phosphatase domain and an N-
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and PtdIns(3)P to PtdIns (Fig. 1A) [10]. A C-terminal proline-rich
domain interacts with specific combinations of partner proteins,
interactions that affect intracellular localization of Synj2 [13].
Synj1 knockout mice die shortly after birth, exhibiting neurological
defects, correlating with increased levels of PtdIns(4,5)P2 and an
accumulation of clathrin-coated vesicles (CCVs) in nerve terminals
[14,15]. Defects in Synj1 also cause slowed endocytosis, depletion
of synaptic vesicles, accumulation of CCVs and aggregation of
cortical actin at neuromuscular junction synapses in C.elegans,
Drosophila and zebrafish [16,17,18,19]. Although no mutant Synj2
mice have so far been reported, it has been proposed Synj2 may
represent a candidate gene for male mouse sterility [20].
To identify novel genes that contribute to deafness we
undertook a phenotypic driven approach in which mice at the
Australian Phenomics Facility (APF) were ENU mutagenised and
progeny were screened for recessively inherited hearing loss. In
one of our strains, Mozart, we have identified the causative
mutation to be in the Synj2 gene, which has not previously been
associated with deafness. The causative mutation in Synj2 is located
in a critical catalytic residue in the 5-phosphatase domain and
results in loss of 5-phosphatase activity. In Mozart this mutation
leads to gradual hearing loss accompanied by hair cell degener-
ation. This study identifies Synj2 as a critical regulator of hair cell
survival that is essential for maintaining normal hearing.
Results
A Synj2 Mutation is Responsible for Hearing Loss in the
Mozart Mouse
The Mozart mouse was identified in a mouse ENU mutagenesis
program in which G3 offspring of ENU-mutagenised mice were
screened for recessively inherited hearing loss. To identify the
causative mutation in the Mozart mouse, genome-wide microsat-
ellite marker analysis on DNA from 20 affected F2 mice was
completed. The results showed linkage to D17Mit113 on
chromosome 17 with a LOD score of 4.5. Fine mapping of 69
affected mice using amplifluor SNP assays narrowed the candidate
region to a 2.1Mb interval between rs13482843 and rs13482851.
The coding regions of all 8 known protein coding genes within this
region were sequenced and the only change found was in the Synj2
gene. The causative mutation in Mozart is a T to A nucleotide
change at nucleotide 1641 (c.1641T.A) in the Synj2 mRNA
(Ensembl transcript ENSMUST00000061091). This results in a
p.Asn538Lys (N538K) substitution (UniProtKB/Swiss-Prot data-
base Q9D2G5) in the highly conserved catalytic 5-phosphatase
domain of the enzyme (Fig. 1A and 1B). Previous studies have
predicted that this Asn orientates a catalytic Asp by forming a
hydrogen bond and mutation of this residue results in a complete
loss in the ability of INPP5A to hydrolyze Ins(1,4,5)P3 [21,22]. To
investigate the effect of the N538K mutation on Synj2 phospha-
tase activity, GST-tagged wild-type and mutant Synj2
N538K 5-
phosphatase domains were expressed in E. coli, purified and
analyzed for 5-phosphatase catalytic activity in hydrolyzing
PtdIns(3,4,5)P3 to form PtdIns(3,4)P4. While the wild-type Synj2
effectively hydrolysed PtdIns(3,4,5)P3 generating PtdIns(3,4)P2, the
Synj2
N538K construct exhibited no 5-phosphatase activity (Fig. 1C).
Similarly, wild-type Synj2 degraded PtdIns(4,5)P2 forming
PtdIns(4)P, but the Synj2
N538K mutant construct exhibited no 5-
phosphatase activity at the same protein concentration (Fig. 1D).
Therefore in Synj2, like other 5-phosphatase family members,
mutation of the conserved Asp
538 residue results in loss of 5-
phosphatase catalytic activity.
Synj2
N538K/N538K Mice Show a Progressive Sensorineural
Hearing Loss without Vestibular Dysfunction
Auditory function was analyzed in Synj2
N538K/N538K mice by
measuring auditory brainstem response (ABR). Synj2
N538K/N538K
mice are born with normal hearing, but their hearing deteriorated
by 8 weeks. By 12 weeks the mice were severely deaf. Fig. 2 shows
the hearing profiles of Synj2
+/+, Synj2
N538K/+ and Synj2
N538K/N538K
mice at 4, 8, 12 and 24 weeks. A minimum of 20 mice were
included in each group. Heterozygous mice showed a similar
audiological profile as wild-type mice. No circling or head tossing/
tilting behavior indicative of a vestibular dysfunction was observed
in Synj2
N538K/N538K mice. When we examined the hearing in F2
progeny from the C57BL/6 Synj2
N538K/N538K outcross with the
CBA/H mapping strain we noted that a milder deafness
phenotype was evident in 25% of the offspring. The hearing
thresholds in these mice would be approximately 30dB lower than
the C57BL/6 Synj2
N538K/N538K mice. This was not the case if
Synj2
N538K/N538K mice were intercrossed with a BALB/c strain,
suggesting the interaction of one or more modifier genes from the
C57BL/6 background. Genotyping showed that the cadherin 23
Ahl variant (Cdh23
ahl) is responsible for modifying the severity of
the Synj2-associated hearing loss (results not shown).
Neurological and Behavioral Studies in Synj2
N538K/N538K
Mice
As mutations in genes regulating phosphoinositide signalling
pathways are often associated with neurological features [12,23],
we examined peripheral nerve conductance in Synj2
N538K/N538K
mice. Fig. 3A shows the time from application of the sciatic
stimulus pulse to the first and second muscle response in 6
Synj2
N538K/+ and 6 Synj2
N538K/N538K mice. Much of the variation
in these data is likely to be due to a slight variation in the position
of the stimulating electrode along the sciatic nerve. It is clear
however, that there was no systematic variation in the latency
between Synj2
N538K/+ and Synj2
N538K/N538K mice. Nerve conduc-
tance was also examined directly by determining the difference in
latency of the first peak when changing the point of nerve
stimulation by a known distance. This was analyzed in mice used
previously in the nerve conductance test (numbers 4 to 12). The
conduction velocities range from 16–23 meters/second across the
8 mice and no significant differences between Synj2
N538K/+ and
Synj2
N538K/N538K mice were detected (Fig. 3B).
Primary behavioral screens of Synj2
+/+ and Synj2
N538K/N538K
mice consisting of locomotor, light dark test, Y-maze, tail
suspension, hot plate and marble burying tests, did not reveal any
significant differences between wild-type and Synj2
N538K/N538K
mice.
The mutant Mozart mice have a normal life span, are fertile and,
apart from the hearing loss, do not appear to have any additional
clinical or behavioural manifestations.
Degeneration of Hair Cell Structure and Stereocilia
Morphology in Synj2
N538K/N538K Mice
Examination of outer and middle ear structures did not identify
any visible structural changes in Synj2
N538K/N538K mice compared
to wild-type mice. Gross structural changes in the inner ear were
initially examined by hematoxylin and eosin (H&E) staining of
cochlear sections. We observed a gradual loss of inner and outer
hair cells in 8 and 12 week old mutant mice, starting in the basal
turn of the cochlea and spreading towards the apical region, leading
to a collapse of the Organ of Corti (Fig. 4). At the same time there
was a reduction in the number of spiral ganglia cells and the
remaining cells showed increased vacuolation. Synj2
N538K/+
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PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17607Figure 1. The N538K mutation abolishes Synj2 inositol polyphosphate 5-phosphatase activity. Domain structure of Synj2 indicating the
position of the N538K mutation in the 5-phosphatase domain (Panel A). The phosphoinositide substrates hydrolyzed by the Sac1 and 5-phosphatase
domains are indicated. Protein sequence alignment of murine 5-phosphatases showing N
538 (boxed) is conserved in all 10 mammalian 5-
phosphatases (Panel B). Accession numbers: Synj2: Q9D2G5, Synj1: NP_001157955, Type I: AAH56341, Type II: CAM16097, SHIP1: Q9ES52, SHIP2:
Q6P549, PIPP: AAI31635, INPP5E: NP_149125, SKIP: NP_032942, OCRL: NP_796189. GST-Synj2 wild-type or Synj2
N538K mutant 5-phosphatase domains
or GST alone were purified from E. coli and assayed for PtdIns([
32P]3,4,5)P3 5-phosphatase activity (Panel C). Lipid products were separated by thin
layer chromatography (top left panel). The migration of PtdIns(3,4)P2 and PtdIns(3,4,5)P3 are indicated. The relative amount of recombinant protein
added to each reaction was determined by immunoblotting with GST antibodies (lower left panel). The relative percentage of PtdIns(3,4,5)P3
substrate hydrolyzed was determined by densitometry (right panel). Bars represent mean 6 SEM from 3 independent experiments. **p,0.001.
Recombinant GST-Synj2 wild-type or Synj2
N538K mutant 5-phosphatase domains or GST alone were purified from E. coli and assayed for PtdIns(4,5)P2
5-phosphatase activity (Panel D). Phosphate release (pmol/25 ml sample) was measured using a malachite green assay (left panel). Bars represent
mean 6 SEM from 2 independent experiments. The relative amount of recombinant protein added to each reaction was determined by Western
blotting with GST antibodies (right panel). **p,0.001.
doi:10.1371/journal.pone.0017607.g001
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degeneration or loss of spiral ganglion neurons (data not shown).
The process of degeneration of the organ of Corti around the
time of the onset of hearing impairment was examined in more
detail by ultrastructural analysis using scanning electron micros-
copy (SEM). Cochleae from 2, 4, 8 and 12 week old mice were
analyzed (Fig. 5). Degeneration of outer hair cells and fusion of
stereocilia was apparent as early as two weeks in the basal cochlear
region (Fig. 5C and 5D). At four weeks of age (Fig. 5E, 5F, 5G,
5H) signs of degeneration were seen in all turns of the cochlea,
although most evident at the basal turn (Fig. 5G, 5H). Both inner
and outer hair cells showed fusion of the stereocilia, and basal
outer hair cells appear sunken and withdrawn from neighboring
supporting cells (Fig. 5H). At eight weeks of age, hair cell
degeneration was more pronounced. In the basal cochlear turn,
the majority of outer hair cell hair bundles were missing, and those
that remained showed extensive stereocilia fusion (Fig. 5K). Some
hair bundles were also missing from the outer hair cells of the mid
cochlear turn (Fig. 5J). At 12 weeks of age, the basal region of the
cochlea was completely void of outer hair cell hair bundles and
inner hair cells showed extensive stereocilia fusion and loss
(Fig. 5O). Degeneration of apical and mid regions of the cochlea
also progressed; the majority of hair cells exhibited fused
stereocilia, and many outer hair cells lacked hair bundles
(Fig. 5M, 5N). At each time-point investigated, degeneration of
the outer hair cells appeared more advanced and severe than that
of the inner hair cells of the same cochlear region.
No Loss of Nerve Fibers in Synj2
N538K/N538K Mice
Hair cells are often the primary site of damage in sensorineural
hearing loss, with the degeneration of cochlear nerve fibers a
secondary consequence [24]. The loss of these fibers has been
reported in a number of mouse models for hearing loss [25,26], and
in mice exposed to harmful levels of noise [27]. To determine
whether loss of cochlear nerve fibers underlies the hearing loss in
Synj2
N538K/N538K mice, antibodies were used to detect neurofilament
NF-L and neurofilament 200kD (NF-H) in cryosections of 12 week
Synj2
+/+ and Synj2
N538K/N538K mice. NF-L expression was evident in
fibers of the cochlear nerve in wild-type and Synj2
N538K/N538K
mice, when compared to an isotype control (Fig. 6). No apparent
differences in the levels of expression of NF-L or NF-H (data not
shown), or in the number of fibers, were observed between Synj2
+/+
and Synj2
N538K/N538K mice by this method. Estimating neuronal fiber
density or individually counting peripheral axons would however
provide a more sensitive and accurate method to determine any
discrete differences between genotypes.
Synj2 is Expressed in the Hair Cells, but not the Spiral
Ganglion of the Inner Ear
As Synj2 mutant mice exhibit deafness, in situ hybridization was
performed to determine the site of Synj2 expression within the
cochlea (Fig. 7). In wild-type Synj2
+/+ adult mice, Synj2 mRNA
expression was detected in the inner and outer hair cells (Fig. 7A
and 7B), but was not observed in the spiral ganglion. In
Synj2
N538K/N538K mutants, Synj2 expression was detected at 4
weeks of age, but was not observed at 8 and 12 weeks following the
degeneration of hair cells and collapse of the organ of Corti
(Fig. 7C and 7D). Expression of the highly related paralog enzyme,
Synj1, was investigated in 12 week old mice. In contrast to Synj2,
expression of Synj1 was not detected in hair cells, but was highly
Figure 2. Synj2
N538K/N538K mutant mice show progressive age-
related hearing loss. Hearing thresholds (dB SPL) in Synj2
+/+,
Synj2
N538K/+ and Synj2
N538K/N538K mice at age 4, 8, 12 and 24 weeks.
Hearing threshold values shown are averages of at least 20 mice per
genotype and error bars represent the standard deviation.
doi:10.1371/journal.pone.0017607.g002
Figure 3. Synj2
N538K/N538K mice exhibit normal nerve conduction. Measurements of the time from application of a sciatic stimulus pulse to
the first (squares) and second (crosses) muscle response (Panel A). Mice numbered 1–6 (orange) are Synj2
+//N538K littermates and mice number 7–12
(blue) are Synj2
N538K/N538K mutants. Conduction velocity (CV) of motor nerves to the gastrocnemius muscle (Panel B). The Average CV is shown (Av)
and error bars represent the standard deviation in the 3 Synj2
+/N538K and 6 Synj2
N538K/N538K mice.
doi:10.1371/journal.pone.0017607.g003
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Synj1 expression was still evident in remaining spiral ganglion cells
in the Synj2
N538K/N538K mouse, despite obvious degeneration of
the spiral ganglion neurons (Fig. 7G). No differences in Synj1 and
Synj2 expression levels or patterns were observed when heterozy-
gotes and wild-type mice were compared. We conclude that Synj2,
but not Synj1, is expressed in the hair cells of the inner ear.
Discussion
This study has identified a novel regulator of hair cell survival,
which is essential for normal hearing, as the phosphoinositide
signal regulating enzyme, Synj2. We have identified a mouse
mutant with a non-syndromic, recessively inherited, progressive
hearing loss due to an ENU-induced mutation in the Synj2 gene.
Synj2
N538K/N538K mice exhibit a rapidly progressive hearing loss
and at 12 weeks of age are severely deaf. The ABR hearing
thresholds in heterozygous Synj2
N538K/+ mice are similar to those
in wild-type littermates and the hearing loss in Mozart is therefore
recessively inherited. Synj2
N538K/N538K mice do not exhibit circling
or head tossing behavior, and respond normally in the simple
trunk curl test. We therefore conclude that they do not have
vestibular dysfunction. Scanning electron microscopy of cochleae
from postnatal day 4 (P4) Synj2
N538K/N538K mice suggests that hair
cells have developed normally (data not shown). However, they
show signs of degeneration as early as two weeks of age. Initial
stages of degeneration include fusion of stereocilia followed by
complete loss of hair bundles and ultimately loss of hair cells,
which is most profound at the basal cochlear region. Outer hair
cells begin to degenerate earlier than inner hair cells and show the
most profound degeneration. As the neurofilament numbers are
normal in Synj2
N538K/N538K mice, it is likely that loss of such fibers
is not the underlying cause of hearing loss in these mice. It
therefore appears that Synj2 is essential for hair cell survival and
normal hearing.
Synj2 is a member of the inositol polyphosphate 5-phosphatase
family, of which ten mammalian enzymes have been character-
ized, many of which exhibit diverse roles in physiological function.
Synj1 and Synj2 are two closely related 5-phosphatases [10,28],
that contain an N-terminal catalytic domain (Sac1) involved in
hydrolysis of additional phosphoinositides [29] followed by a
central 5-phosphatase domain that hydrolyses the 5-position
phosphate from the inositol ring of PtdIns(4,5)P2, PtdIns(3,4,5)P3
and Ins(1,4,5)P3 (Fig. 1). Mice with mutations in Synj1 die shortly
after birth due to neurological complications [14] associated with
the accumulation of clathrin-coated vesicles in the nerve terminals
as a consequence of failure to degrade PtdIns(4,5)P2. Deafness or
inner ear abnormalities have not been reported in Synj1 mice and
Synj1 is not expressed at detectable levels in adult mouse hair cells.
However, expression of Synj1 has been previously reported in adult
zebrafish hair-cell transciptome using amplified RNA [30], and
more recently in developing hair cells of zebrafish larval by in situ
hybridization analysis [31], and synaptosomes from 2 week old
chicken cochleae using microarray and western blot analysis [32].
Synj1 has been implicated in hair cell function in zebrafish. Synj1-
deficient nrc and comet zebrafish mutants revealed impaired
vestibular–ocular defects with normal startle acoustic response
[31,33,34]. Examination of the Synj1
Q296X mutant zebrafish
neuromast hair cells showed blebbing near synaptic ribbons. It
was shown that this is a consequence of an imbalance between
exo- and endocytosis and dependent on Cav1.3 calcium channel
activity. Electrophysiological investigations revealed decreased
number of readily releasable vesicles and far fewer reserve pool
vesicles, as well as defective phase locking of afferent activity. Synj1
was proposed to play a critical role in facilitating vesicle recycling
Figure 4. Synj2
N538K/N538K cochleae exhibit degeneration. Synj2
+/+ (Panels A, B and C) and Synj2
N538K/N538K (Panels D, E and F) cochleae were
sectioned at 4 (Panels A and D), 8 (Panels B and E) and 12 (Panels C and F) weeks of age and H&E stained. Representative cochleae are shown.
Synj2
N538K/N538K cochleae show signs of degeneration at 8 and 12 weeks of age, with evidence of collapse of the organ of Corti (arrow head, panels E
and F) and degeneration of spiral ganglion neurons (arrow, panels E and F). SG, spiral ganglion; OC, organ of corti; OHC, outer hair cells; IHC, inner hair
cell. Scale bar: 100 mm.
doi:10.1371/journal.pone.0017607.g004
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release [31]. The absence of detectable Synj1 expression in hair cell
in 12 week old mice in this study could reflect the limited
sensitivity of the technique utilized and/or indicate a restricted
temporal expression of Synj1 in mouse hair cells. Synj2 is a much
less characterized enzyme, and our Synj2
N538K/N538K mice are the
only reported mouse strain with a mutation in the Synj2 gene (the
gene affected in a mouse mentioned in [35] appears to be in Synj1
and not in Synj2). Therefore our study represents the first
association of Synj2 with a disease phenotype.
The mutation in Synj2, p.N538K, leads to significant loss of
catalytic activity towards two of its substrates, PtdIns(3,4,5)P3 and
PtdIns(4,5)P2. The Synj2 Asn
538 residue is highly conserved in
species as divergent as Drosophila and yeast. Whisstock et al
mutated the corresponding asparagine to an alanine in the mouse
43 kDa inositol polyphosphate 5-phosphatase (encoded by the
Inpp5a gene) and showed that this residue is essential for catalytic
hydrolysis of Ins(1,4,5)P3 [22].
Phosphoinositides are components of eukaryotic cell mem-
branes that act as signaling molecules, regulating many cellular
processes including actin polymerization, apoptosis and vesicular
membrane trafficking [14,36,37,38,39,40,41,42]. Mutations in
genes affecting phosphoinositide metabolism can therefore be
expected to have important consequences for cell function and
survival. Mozart’s relatively mild phenotype is somewhat unex-
pected, especially since the p.Asn538Lys Synj2 mutation appears to
significantly ablate 5-phosphatase activity in enzyme assays.
Although we are unable to yet explain the mild phenotype of
Figure 5. Loss of function of Synj2 leads to cochlear hair cell loss. Ultrastructural analysis using scanning electron microscopy of cochlear hair
cells in Synj2
N538K/N538K and Synj2
+/+ mice. Apical, mid and basal cochlear turns were examined at 2, 4, 8 and 12 weeks of age. As early as 2 wks of age,
signs of hair cell degeneration are seen in outer hair cells of the basal cochlear turn (Panel D). At 4 weeks, the majority of basal outer hair cells appear
sunken with fused stereocilia (Panel H). Mid cochlear inner hair cells show stereocilia fusion at 8 weeks (Panel L). Fused stereocilia or complete losso f
hair bundles is common in mid region outer hair cells at 12 weeks (Panel P). Panel T shows the structure of a normal outer hair cell. OHC, outer hair
cells; IHC, inner hair cells. Scale bar: 4 mm.
doi:10.1371/journal.pone.0017607.g005
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N538K/N538K mice, we can suggest several possible
explanations: first, the mutated Synj2
N538K enzyme may have
enough residual phosphatase expression to allow normal cell
function, except in the hair cells where our in situ results suggest a
higher level of Synj2 activity is present and may be required for
cell function; second, Synj2 has several important domains that
function independently from the 5-phosphatase activity. These
functions are retained in our mutant mouse and the lack of Synj2
5-phosphatase activity could be largely compensated for in mice
(apart from within the cochlea) by other 5-phosphatases [43];
third, Synj2
N538K protein may bind its substrate PtdIns(4,5)P2
and/or PtdIns(3,4,5)P3, but not release it, thereby affecting an
inner ear specific function, or fourth, low levels of Synj1,
undetectable by in situ hybridisation, may compensate for the lack
of Synj2 5-phosphatase activity in the mutant in a temporal
fashion. In support of this hypothesis the detection of phospho-
inositide biosensors, AKT/PH-GST or PLCd ˜1PH-GST, by
immunohistochemistry in tissue sections from wild-type versus
Synj2
N538K/N538K mice did not identify any detectable difference in
their distribution or levels.
It is known that inositol phosphates and phosphoinositides do
play an important role in hearing. PtdIns(4,5)P2 is hydrolyzed by
phospholipase C to generate Ins(1,4,5)P3 which mobilizes
intracellular calcium. Ins(1,4,5)P3 and ATP release in cochlear
cells leads to the propagation of regenerative Ca
2+ waves,
intracellular free Ca
2+ that spreads through cells supporting the
sensory cells [6,44,45,46]. This intracellular signaling affects
important cellular processes [47], some of which might be essential
for correct sound processing [46]. A number of connexin 26
mutations have been reported in people with hearing loss, causing
impaired Ins(1,4,5)P3 connexin hemichannel permeability [7,9],
therefore demonstrating that this is a process essential for
propagation of Ca
2+ waves and normal cochlear function [8].
Mechanisms for sensing damage to sensory hair cells from acoustic
trauma have also been linked to the availability of functional
Ins(1,4,5)P3 stores in supporting cells [48]. Hirono et al showed that
PtdIns(4,5)P2 itself plays an essential role in hair cell transduction
and adaptation in frogs [49]. Mice with mutations in the
transmembrane phosphatidylinositol phosphatase gene Ptprq [50]
develop abnormal hair cell stereocilia, most likely from altered
actin organization, or turnover, as well as changes to membrane
trafficking due to changes in phosphoinositide levels in hair cells
[51]. Phosphoinositides are also involved in mediating ototoxicity
of aminoglycoside antibiotics [52,53] through a process involving
formation of reactive oxygen species [54]. PtdIns(3,4,5)P3 has been
associated with a decline of survival capacity in ageing outer hair
cells [55]. PtdIns(4,5)P2 has been shown to play a significant role in
regulating ion channel activity, including potassium channels such
Figure 6. Neurofilament expression in Rosenthal’s canal. Expression of NF-L in cochlear nerve fibres (red) of Synj2
+/+ (Panel A) and
Synj2
N538K/N538K mice (Panel B) within the Rosenthal’s canal (dotted line). Isotype control showing no non-specific expression (Panel C). OSL, osseas
spiral lamina; RC, Rosenthal’s canal. Scale bar: 20 mm.
doi:10.1371/journal.pone.0017607.g006
Figure 7. Synj2 but not Synj1 is expressed in the hair cells of the mouse cochlea. Synj2 expression (blue staining) within the inner and outer
hair cells of Synj2
+/+ mice at 4 weeks (Panel A) and 12 weeks (Panel B), and Synj2
N538K/N538K mice at 4 weeks (Panel C) and 12 weeks (Panel D). Control
Synj2 sense probe staining is shown in Panel E. Synj1 expression in Synj2
+/+ (Panel F) and Synj2
N538K/N538K (Panel G) spiral ganglion in 12 week old
mice. Control sense Synj1 probe staining is shown in Panel H. IHC, inner hair cells; OHC, outer hair cells; SG, spiral ganglion. Scale bar: 50 mm.
doi:10.1371/journal.pone.0017607.g007
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KCNQ4, which is expressed in the hair cells of the inner ear,
underlie DFNA2, a subtype of autosomal dominant progressive,
high-frequency hearing loss. Mice with loss of function of KCNQ4
exhibit normal vestibular function, but have progressive hearing
loss associated with loss of the outer hair cells, reminiscent of
Synj2
N538K/N538K Mozart mice [57]. Therefore it is tempting to
speculate that loss of Synj2 function in degrading PtdIns(4,5)P2
leads to altered KCNQ channel activity and hair cell degenera-
tion.
Mutations in other lipid phosphatases that regulate phospho-
inositide signaling molecules have been associated with abnormal
neurological function. Recently Inpp4a, an enzyme that degrades
PtdIns(3,4)P2, the lipid product of 5-phosphatase hydrolysis of
PtdIns(3,4,5)P3, was identified as a suppressor of neuroexcitatory
cell death [58]. Pale tremor mice have light fur pigmentation, severe
tremors and abnormal gait due to a mutation in the Fig4 gene,
coding for a PtdIns(3,5)P2 5-phosphatase [59]. In humans,
mutations in FIG4 cause Charcot-Marie-Tooth type 4J neuropa-
thy [59]. We therefore investigated if Synj2
N538K/N538K mice had
more subtle neurological features by measuring nerve conductance
in the sciatic nerve, as well as conducting a primary behavioral
screen. However, homozygous mutant mice did not show any
statistically significant differences from Synj2
N538K/+ littermates.
Mouse models of disease are often excellent models of human
conditions. Analysis of human DNA samples to determine if
mutations in the SYNJ2 gene cause hearing loss in humans is in
progress.
Although studies are beginning to provide an insight into the role
of some phosphoinositides in hearing loss, the specific mechanisms
of how the p.Asn538Lys mutation in Synj2
N538K/N538K mice causes
a progressive, non-syndromic hearing loss, and the role of
phosphoinositides in this process is not yet understood. Further
characterization of our novel Synj2
N538K/N538K mouse model will
provide new insights into the functional and structural features of
the auditory system, and the role of Synj2 and phosphoinositides in
the auditory process.
Materials and Methods
The Mozart Mouse
The Mozart mouse was generated at the Australian Phenomics
Facility (APF) as part of a mouse ENU mutagenesis program (http://
www.australianphenomics.org.au/services.html). Male C57BL/6
mice were treated weekly for 3 weeks with 100 mg/kg N-ethyl-N-
nitrosourea (ENU). To identify recessive phenotypes, G2 siblings
were mated to generate consanguineous G3 offspring homozygous
forENUmutations.RecessiveinheritancewasvalidatedintheMozart
strain by backcrossing deaf mice onto wild-type C57BL/6 mice
followed by brother-sister matings, to confirm that approximately
25% of the offspring had a hearing loss. All mouse procedures were
approved by the Royal Children’s Hospital Animal Ethics Commit-
tee, RCH AEEC #A488 and #A585.
Hearing Testing of Mice
G3 offspring of ENU-mutagenised mice were initially screened
for hearing loss using a clickbox that elicits a Preyer reflex or
startle response in hearing mice. The clickbox produces an
18.9 kHz burst of 106 dB SPL at a distance of 10 cm (Institute of
Hearing Research, Nottingham, UK). It provided a convenient,
fast, low-cost and thus suitable high-throughput phenotypic
screen. Mice that failed the initial clickbox hearing test had a
more detailed assessment of possible hearing loss using an evoked
auditory brainstem response (ABR) test (AEP, Bio-logic Systems
Corp.). Subdermal active, reference and ground electrodes were
placed at the vertex, ventrolateral to the left ear and the abdomen,
respectively, of the anaesthetized mouse. Specific auditory stimulus
in the form of broadband clicks was delivered in a range of decibel
sound pressure levels (dB SPL) and the ABR recorded. Subsequent
offspring were then screened by ABR to obtain a hearing profile
for each genotype. Mice were also screened for the presence of
vestibular dysfunction, identified by the display of hyperactivity
that manifests either as circling, head tossing/tilting and/or star
gazing behaviour.
Mapping and Mutation Detection
Deaf Mozart mice were outcrossed with the CBA/H mapping
strain and the Mozart/CBA/H offspring were then crossed to each
other to produce affected F2 generation mice for homozygosity
mapping. Genomic DNA (isolated by phenol/chloroform extrac-
tion from tail biopsies) from 20 affected mice were analyzed by
genome wide scans using 120 microsatellite markers (AGRF,
Australia). Fine mapping was performed using Amplifluor-based
SNP assays (APF, Australia) on 69 additional affected mice. For
statistical analysis we used the normal approximation to the
binomial test for proportions of homozygous C57BL/6 genotypes
(hearing loss mutants), to map the deafness loci. In regions of
linkage, the proportion of homozygous C57BL/6 genotypes would
approach 1.0 whilst at unlinked loci this proportion would be 0.25.
Linkage intervals were examined for known or putative deafness
genes using the UCSC genome browser. PCR primers were
designed to amplify and sequence the coding regions, intron-exon
boundaries and the 59 and 39 untranslated regions of candidate
genes. Primer sequences are available upon request. Sequencing
was performed using BigDye terminators V3.1 (ABI).
Site-directed Mutagenesis and 5-Phosphatase Enzyme
Assay
Synj2 or Synj2
N538K 5-phosphatase domains were sub-cloned
into the pGEX-KG vector in-frame with the GST tag. Expression
of recombinant GST-tagged proteins was induced in E.coli by
incubation of 50 ml cultures of cells with 0.1 mM IPTG for
3 hours at 30uC. Cell pellets were suspended in 5 ml GST
extraction buffer (50 mM HEPES (pH 7.5), 150 mM NaCl,
1 mM EDTA, 10 mM MgCl2) + 1% Triton X-100, 1 mM
PMSF, 0.2 mg/ml aprotinin, 0.2 mg/ml leupeptin, 1 mM benza-
midine and incubated at 4uC for 90 minutes with gentle agitation.
Lysates were centrifuged at 13,000 g for 10 minutes then the
supernatants incubated with 100 ml pre-washed glutathione
Sepharose
TM 4B beads overnight at 4uC with rotation. Samples
were washed 6 times in ice-cold GST extraction buffer then
PtdIns(3,4,5)P3 or PtdIns(4,5)P2 5-phosphatase assays were
performed on the affinity precipitates. For PtdIns(3,4,5)P3 5-
phosphatase assays, 50 ml PtdIns([
32P]3,4,5)P3 prepared as de-
scribed [60] was added to the affinity precipitates together with
4 ml 20 x kinase buffer (400 mM HEPES (pH 7.5), 100 mM
MgCl2, 20 mM EGTA). Reactions were incubated at 37uC for 20
minutes and the lipids extracted and analyzed by TLC as
previously described [60]. For PtdIns(4,5)P2 5-phosphatase assays,
5 mg PtdIns(4,5)P2 (Echelon Biosciences, Salt Lake City, UT) was
added to 40 ml of the affinity precipitates together with 55 ml1x
kinase buffer. Reactions were incubated at 37uC for 30 minutes
then 20 ml supernatants and 80 ml malachite green (Echelon
Biosciences) were added to a 96 well plate in duplicate, incubated
at room temperature for 15 minutess and the absorbance
measured at 655 nm. Phosphate release was quantitated according
to the manufacturer’s instructions.
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Adult mice were anaesthetized with isoflurane and culled by
cervical dislocation according to the National Health and Medical
Research Council Australian code of practice for the care and use
of animals for scientific purposes. Intact cochleae were surgically
removed using a posterolateral approach, as described previously
[61]. Brains and other tissues were dissected from mice when
needed for further analysis.
Hematoxylin and Eosin (H&E) Staining
Cochleae were isolated from 4, 8 and 12 week Synj2
+/+,
Synj2
N538K/+ and Synj2
N538K/N538K mice. Tissues were fixed in
4% paraformaldehyde (PFA) for 1–1.5 hours at room temperature
with rotation, washed 3 x 5 minutes in TBS, and then transferred to
10% EDTA for 4–7 days at 4uC to decalcify. Decalcified cochleae
were washed through a series of increasing sucrose solutions and
incubated overnight at 4uC in 30% sucrose/PBS, then transferred
to OCT (Sakura, USA) and left overnight at 4uC to allow the OCT
to fully penetrate the tissue. Cochleae were embedded in OCT,
sectioned (10 mm) using a Leica cryostat and placed onto Superfrost
Plus microscope slides (Thermo Scientific, USA). Sections were
dried at room temperature and stored at 220uC until required.
Sections were then subjected to standard H&E staining.
Immunohistochemistry
Cochleae were prepared as described above for H&E staining.
Cryosections were thawed at room temperature for a minimum of
30 minutes, washed 3 x 10 minutes in PBS and then incubated
with 0.3% Triton X-100 for 20 minutes to permeabilise the tissue.
Slides were then briefly washed in PBS and incubated with Image-
iT FX Signal Enhancer (Invitrogen) for 30 minutes in a humidified
chamber at room temperature to reduce background staining.
Slides were washed a further 3 x 10 minutes with PBS, and pre-
blocked in Blocking Solution (30% goat serum (GS), 2% BSA and
0.3% Triton X-100 in PBS) for 30 minutes before incubation with
primary antibody in 1% GS, 0.1% Triton X-100 in PBS overnight
at 4uC. Slides were washed for 3 x 10 minutes in PBS and
incubated for a further 2 hours in the dark with an Alexa Fluor
594-conjugated goat anti rabbit IgG antibody or a 488-conjugated
donkey anti mouse IgG antibody (both 1:1500; Molecular Probes)
in 1% GS/PBS. Slides were washed an additional 3 x 10 minutes
and mounted with ProlongH Gold antifade reagent with DAPI
(Invitrogen). Slides incubated with primary antibodies omitted the
incubation step with anti-GST antibody. Fluorescence was
analysed using a Leica TCS SP2 laser scanning confocal
microscope, and images generated with Leica Confocal Software
(Leica Microsystems).
Primary antibodies used were anti-neurofilament NF-L mono-
clonal antibody (1:500; Covance), anti-neurofilament 200kD
polyclonal antibody (1:500; Chemicon), purified mouse IgG1
(1:500; Invitrogen) and rabbit serum (1:500; Sigma).
In Situ Hybridization
Cochleae were isolated and then processed for in situ hybridiza-
tion as previously described [61]. Digoxigenin-labelled (DIG RNA
labelling mix, Roche) anti-sense and sense riboprobes for Synj1 and
Synj2 were generated by nested PCR, using cDNA made from RNA
isolated from snap frozen brains of wild-type mice. For Synj2 the
following primers were used to create a 542 bp riboprobe: Synj2
ExtF 59-GCTTTTGAAAGGCACATGGT-3, Synj2 ExtR 59-
AGCATCCGTCCTTTGTCTGT-39, Synj2 IntF T7 59-GAG-
TAATACGACTCACTATAGGAAGTTGCTCTGGGCTTCT-
TG-39, Synj2 IntR Sp6 59-TGTATTTAGGTGACACTATA-
GAACAGTAGCTTGATGGCCTCCT-39. For Synj1, the following
primers were used to create a 619 bp riboprobe: Synj1 ExtF: 59-
GCAGTTTGCACAC TTTGGTG-39, Synj1 extR: 59-GGGCT-
TTTGGGTGCTTCTAT, Synj1 IntF T7: 59-GTGTAATACGACTCAC-
TATAGGGAAGCTCTGCCTTGAA-39, Synj1 IntR Sp6: 59-TATATT-
TAGGTGACACTATAGACTAGCAGGCGCAGGACTC-39. Riboprobe
hybridization was visualized using an Anti-Digoxigenin-Alkaline Phosphatase
conjugated antibody (Roche) and BCIP/NBT (Roche) color reaction.
Scanning Electron Microscopy (SEM)
For SEM analysis, inner ears were isolated, the round and oval
windows were cleared and the cochlear apex was pierced to allow
thorough perfusion of the fixative. Inner ears were fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) with
3 mM CaCl2 for 3 hours at room temperature. Samples were then
washed in PBS and further dissected by removing the bony shell,
stria vascularis, Reissner’s and tectorial membranes, to reveal the
cochlear sensory epithelium. Four, 8 and 12 week cochlear
specimens were processed with the OTOTO method (osmium
tetroxide/thiocarbohydrazide) adapted from Hunter-Duvar et al
[62], then dehydrated in ethanol, critical point dried (CPD 20,
Bal-Tec), mounted on stubs using conductive silver paint and
viewed using a Hitachi FE S-4800 Scanning Electron microscope.
Cochleae from 2 week old mice, and some additional 12 week
mice, were coated with osmium tetroxide for 2.5 hours, washed,
dehydrated in ethanol, critical point dried (CPD 030, Bal-Tec),
mounted on stubs using silver paint, gold sputter coated (Edwards
S150B sputter coater, ,10 nm) and viewed using a Philips XL30
FE Scanning electron microscope.
Nerve Conductance Tests
Peripheral nerve conduction was assessed in two ways by
electromyography (EMG). The sciatic nerve was stimulated and
the time it took for the compound muscle action potential to be
generated was measured. These same recordings were also
investigated for a second peak, indicating that sciatic stimulation
activated Ia sensory fibers in the nerve and evoked a muscle action
potential via their monosynaptic connections with sciatic motor
neurons in the spinal cord. The second method of examining
nerve conduction was to determine nerve conduction velocity
directly by taking the difference in the latency of the first peak
when changing the point of sciatic nerve stimulation by a known
distance. By subtracting the latencies we cancel out any delays in
the generation of the EMG response caused by neuromuscular
transmission and generation of the muscle action potential, and
are left with the difference in latency caused by the change in
distance. This is an accurate way to determine if there are
differences in conduction velocity in different groups of mice,
although the velocities measured by this ‘‘whole nerve’’ stimulation
approach differ from some single fibre measurements.
Behavioral Tests
Primary behavioral screens of 12 wild-type, 12 heterozygous
and 12 homozygous mutant Mozart mice, consisting of locomotor,
light-dark, Y-maze, tail suspension, hot plate, rotarod and marble
burying tests, were done at the Integrative Neuroscience Facility at
the Florey Institute, Melbourne (http://www.hfi.unimelb.edu.au/
inf/).
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